174 related articles for article (PubMed ID: 33759545)
21.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
22. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
23. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
24. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
Lai J; Shah BP; Zhang Y; Yang L; Lee KB
ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
[TBL] [Abstract][Full Text] [Related]
25. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
26. Carbon-Quantum-Dots-Loaded Mesoporous Silica Nanocarriers with pH-Switchable Zwitterionic Surface and Enzyme-Responsive Pore-Cap for Targeted Imaging and Drug Delivery to Tumor.
Liu Z; Chen X; Zhang X; Gooding JJ; Zhou Y
Adv Healthc Mater; 2016 Jun; 5(12):1401-7. PubMed ID: 26987989
[TBL] [Abstract][Full Text] [Related]
27. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
28. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
29. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
30. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
31. pH-responsive controlled release of mesoporous silica nanoparticles capped with Schiff base copolymer gatekeepers: Experiment and molecular dynamics simulation.
Peng S; Yuan X; Lin W; Cai C; Zhang L
Colloids Surf B Biointerfaces; 2019 Apr; 176():394-403. PubMed ID: 30660963
[TBL] [Abstract][Full Text] [Related]
32. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
33. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.
Gui W; Zhang J; Chen X; Yu D; Ma Q
Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582
[TBL] [Abstract][Full Text] [Related]
34. pH- and temperature-responsive radially porous silica nanoparticles with high-capacity drug loading for controlled drug delivery.
Choi Y; Kim J; Yu S; Hong S
Nanotechnology; 2020 Aug; 31(33):335103. PubMed ID: 32369797
[TBL] [Abstract][Full Text] [Related]
35. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
[TBL] [Abstract][Full Text] [Related]
36. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
37. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
38. Dual stimuli-responsive mesoporous silica nanoparticles for efficient loading and smart delivery of doxorubicin to cancer with RGD-integrin targeting.
Kim HS; Kang JH; Jang J; Lee EJ; Kim JH; Byun J; Shin US
Eur J Pharm Sci; 2023 Sep; 188():106525. PubMed ID: 37437854
[TBL] [Abstract][Full Text] [Related]
39. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
40. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
